ACTRN12623001234606招募中Unknown
A single-centre randomised controlled trial of the feasibility and impact on adherence of laboratory or home non-invasive ventilation (NIV) adjustment for adults with chronic respiratory failure: Synchronise NIV@Home
Institute for Breathing and Sleep, Australia0 个研究点目标入组 171 人开始时间: 2023年11月30日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 171
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Medically stable
- •With or at risk of chronic hypercapnic respiratory failure
- •Diagnosis of slowly progressive neuromuscular disease, chronic obstructive lung disease, chest wall disease, COPD/OSA overlap syndrome or obesity hypoventilation syndrome.
- •Clinical indication to commence long term NIV
- •Suitable for short admission to hospital for NIV implementation
排除标准
- •Hypoventilation attributable to medications with sedative/respiratory depressant side-effects
- •Regular use of NIV (> 6 hours/day on average AND usage on >50% of days) over the previous 3 months
- •Geographical – lives more than 2 hours from Austin Health via road
- •No or inadequate support to manage home monitoring equipment or instructions to adjust therapy at home
- •No mobile network coverage
- •Home visit safety risk
- •Non English speaking participant
- •Inability to provide informed consent
研究者
相似试验
已完成
不适用
Modified constraint-induced therapy for children with cerebral palsy: A randomised controlled trialACTRN12607000446460The Children's Hospital at Westmead50
进行中（未招募）
1 期
A single-centre randomised controlled trial of propofol cardioplegia on blood and myocardial biomarkers of stress and injury in patients having isolated coronary artery bypass grafting (CABG) or aortic valve replacement (AVR) using cardiopulmonary bypass (CPB) - Propofol cardioplegia for Myocardial Protection Trial: ProMPTEUCTR2009-015779-28-GBniversity Hospitals Bristol NHS Foundation Trust101
进行中（未招募）
不适用
A pilot single-centre randomised controlled trial of recombinant human erythropoietin versus placebo in primary progressive multiple sclerosis.Primary progressive multiple sclerosisMedDRA version: 9.1Level: LLTClassification code 10063401Term: Primary progressive multiple sclerosisEUCTR2008-005125-11-GBWalton Centre for Neurology and Neurosurgery
已完成
不适用
The clinical and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shockSevere sepsis/septic shockInfections and InfestationsOther septicaemiaISRCTN36307479Intensive Care National Audit and Research Centre (ICNARC) (UK)1,260
进行中（未招募）
3 期
Trial of sertraline to prevent post-traumatic brain injury depressioDepressive disorder after traumatic brain injuryMental and Behavioural DisordersISRCTN17518945King's College Hospital514